Desmoid Tumor clinical trials at University of California Health
2 in progress, 1 open to eligible people
open to eligible people ages 12 years and up
The current study is designed to evaluate the efficacy and safety of AL102 in patients with progressive desmoid tumors.
Sorry, in progress, not accepting new patients
This study evaluates nirogacestat in the treatment of desmoid tumor/aggressive fibromatosis (DT/AF). Half of the participants will receive nirogacestat while the other half will receive placebo.
at UCLA UCSF